Log in or Sign up for Free to view tailored content for your specialty!
Preventive Medicine News
More patient education needed to ensure proper use of aspirin, statins in older patients
Many adults aged at least 75 years are taking aspirin for primary CVD prevention despite lack of evidence, whereas many are not taking statins for primary CVD prevention despite strong evidence, researchers reported.
WHO: Nearly one in four worldwide will have some hearing loss by 2050
WHO’s inaugural World Report on Hearing estimates that about one in four people — or about 2.5 billion — worldwide will have some type of hearing loss by 2050.
Log in or Sign up for Free to view tailored content for your specialty!
USPSTF: Screen all sexually active women, but not men, for chlamydia, gonorrhea
The U.S. Preventive Services Task Force issued a draft recommendation encouraging physicians to screen for chlamydia and gonorrhea in all sexually active women aged 24 years and younger.
Rollout begins for newly approved Johnson & Johnson vaccine
The White House’s COVID-19 response coordinator said Monday that doses of Johnson & Johnson’s one-shot vaccine will be delivered as early as Tuesday.
Statins may reduce CV events in older patients with stroke
Older patients with ischemic stroke who took statins for 2 years after discharge experienced fewer CV events after hospital discharge compared with those who took them for less than 2 years or not at all, researchers reported in Stroke.
Researchers identify attributes that may differentiate MIS-C from COVID-19
A study involving more than 1,000 patients identified cardiac involvement, age and race as attributes that could differentiate multisystem inflammatory syndrome in children from severe COVID-19, researchers reported in JAMA.
Q&A: Inpatient mammograms may help reduce screening disparities
Offering mammograms to low-income, hospitalized women who are overdue to receive one helps reduce barriers to screening that they may face in the outpatient setting, according to researchers.
Q&A: COVID-19 vaccine makers ramp up testing in children
Although the Biden administration has said that enough COVID-19 vaccine doses will be available in the U.S. to vaccinate 300 million people by the end of July, it is still unclear when vaccines will be widely available to children.
Advocating for change: The power of physicians to give voice to patients
Now is a time of transition in our nation. As physicians, regardless of our background or upbringing, we hold positions of power and privilege in society. We must use our power to give voice to our patients and communities.
Klisyri superior to placebo for treatment of actinic keratoses in randomized studies
Klisyri, an FDA-approved Src kinase signaling inhibitor, was superior to placebo for the treatment of actinic keratoses, according to findings from two double-blind randomized trials published in The New England Journal of Medicine.
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read